Therefore, the above data demonstrated that both intracellular and extracellular expression of GRP78 can suppress both the innate and adaptive immunity which may explain why its high expression in breast cancer correlates with tumor progression and poor prognosis (see below). This evidence concerns the gene HSPA5 and breast cancer.